Concepedia

Publication | Closed Access

AXL is a predictor of poor survival and of resistance to anti-EGFR therapy in RAS wild-type metastatic colorectal cancer

DOI

48

Citations

13

References

2020

Year

Claudia Cardone, Bernadette Blauensteiner, Verónica Moreno‐Viedma, Giulia Martini, Vittorio Simeon, Pietro Paolo Vitiello, Davide Ciardiello, Valentina Belli, Nunzia Matrone, Teresa Troiani,
European Journal of Cancer

References

YearCitations

Page 1